Carlo Enrico Traverso

ORCID: 0000-0002-0510-6651 · 1 paper in corpus

letter 2022

Concerns on ranibizumab and zoledronic acid safety for experimentally treating women with endometriosis

Archives of gynecology and obstetrics ·doi:10.1007/s00404-021-06390-3

Correspondence to the original research entitled "Effects of ranibizumab and zoledronic acid on endometriosis in a rat model" published by Ozdemir et al.